{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three familial variants of the presynaptic protein R-synuclein (RS), A30P, E46K, and A53T, correlate with rare inherited Parkinson’s disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the correlation of the A30P variant with inherited Parkinson’s disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation, comparable affinity for A53T, and an increased level of binding of E46K, relative to wild-type RS.",
          "judgment": "Yes",
          "reasoning": "The assay used for this variant effectively models the disease pathogenesis/mechanism, as it measures the lipid binding properties of the disease variants, which are relevant to the aggregation and fibril formation in Parkinson’s disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper provides detailed procedures for protein expression and purification, preparation of lipid vesicles, and NMR spectroscopy, indicating a well-controlled experimental setup."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4a: Statistical Analyses",
          "extracted_paper_info": "The lipid binding affinity of the first 10 N-terminal residues of A30P RS approaches that of the wild-type protein. A segment containing residues 11-23 exhibits progressively increasing resonance intensity, corresponding to an increasing fraction of the disordered population.",
          "judgment": "Yes",
          "reasoning": "The paper provides a detailed analysis of the lipid binding properties of the A30P variant, allowing for the application of the functional evidence to the individual variant interpretation.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4c: Correlate OddsPath",
          "extracted_paper_info": "The absolute fraction of RS bound as SL1 is significantly increased by the E46K mutation, while the relative abundance of binding modes SL1 and SL2 is increased by the A30P and A53T mutations.",
          "judgment": "Yes",
          "reasoning": "The paper suggests that the increase in SL1 levels, associated with the perturbation of the SL1:SL2 distribution, may contribute to the increased toxicity of the A30P disease variant of RS.",
          "next_step_or_outcome": "Determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence supports the pathogenicity of the A30P variant, as it shows a redistribution of lipid-bound states, which may contribute to the increased toxicity associated with Parkinson’s disease."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three familial variants of the presynaptic protein R-synuclein (RS), A30P, E46K, and A53T, correlate with rare inherited Parkinson’s disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the correlation of the E46K variant with inherited Parkinson’s disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation, comparable affinity for A53T, and an increased level of binding of E46K, relative to wild-type RS.",
          "judgment": "Yes",
          "reasoning": "The assay used for this variant effectively models the disease pathogenesis/mechanism, as it measures the lipid binding properties of the disease variants, which are relevant to the aggregation and fibril formation in Parkinson’s disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper provides detailed procedures for protein expression and purification, preparation of lipid vesicles, and NMR spectroscopy, indicating a well-controlled experimental setup."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4a: Statistical Analyses",
          "extracted_paper_info": "The E46K RS variant displays an overall higher level of lipid partitioning of SL1, SL2, and all intermediate modes, relative to that of the wild type.",
          "judgment": "Yes",
          "reasoning": "The paper provides a detailed analysis of the lipid binding properties of the E46K variant, allowing for the application of the functional evidence to the individual variant interpretation.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4c: Correlate OddsPath",
          "extracted_paper_info": "The absolute fraction of RS bound as SL1 is significantly increased by the E46K mutation, while the relative abundance of binding modes SL1 and SL2 is increased by the A30P and A53T mutations.",
          "judgment": "Yes",
          "reasoning": "The paper suggests that the increase in SL1 levels, associated with the perturbation of the SL1:SL2 distribution, may contribute to the increased toxicity of the E46K disease variant of RS.",
          "next_step_or_outcome": "Determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The functional evidence strongly supports the pathogenicity of the E46K variant, as it shows a significant increase in lipid partitioning and a higher membrane affinity, which may contribute to the increased toxicity associated with Parkinson’s disease."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Three familial variants of the presynaptic protein R-synuclein (RS), A30P, E46K, and A53T, correlate with rare inherited Parkinson’s disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which is the correlation of the A53T variant with inherited Parkinson’s disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation, comparable affinity for A53T, and an increased level of binding of E46K, relative to wild-type RS.",
          "judgment": "Yes",
          "reasoning": "The assay used for this variant effectively models the disease pathogenesis/mechanism, as it measures the lipid binding properties of the disease variants, which are relevant to the aggregation and fibril formation in Parkinson’s disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper provides detailed procedures for protein expression and purification, preparation of lipid vesicles, and NMR spectroscopy, indicating a well-controlled experimental setup."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4a: Statistical Analyses",
          "extracted_paper_info": "Among the three disease variants, the A53T mutation has the most subtle effect upon lipid binding.",
          "judgment": "Yes",
          "reasoning": "The paper provides a detailed analysis of the lipid binding properties of the A53T variant, allowing for the application of the functional evidence to the individual variant interpretation.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4c: Correlate OddsPath",
          "extracted_paper_info": "The absolute fraction of RS bound as SL1 is significantly increased by the E46K mutation, while the relative abundance of binding modes SL1 and SL2 is increased by the A30P and A53T mutations.",
          "judgment": "Yes",
          "reasoning": "The paper suggests that the increase in SL1 levels, associated with the perturbation of the SL1:SL2 distribution, may contribute to the increased toxicity of the A53T disease variant of RS.",
          "next_step_or_outcome": "Determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence supports the pathogenicity of the A53T variant, as it shows an increase in the relative abundance of binding modes SL1 and SL2, which may contribute to the increased toxicity associated with Parkinson’s disease."
    }
  ]
}